Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROI

Below are the top diagnostic substances stocks on the NASDAQ in terms of return on investment.

The trailing-twelve-month return on investment at Nymox Pharmaceutical (NASDAQ: NYMX) is 73.80%. Nymox Pharmaceutical's revenue for the same period is $3.30 million.

The trailing-twelve-month return on investment at Meridian Bioscience (NASDAQ: VIVO) is 24.50%. Meridian Bioscience's EPS for the same period is $0.88.

The trailing-twelve-month return on investment at IDEXX Laboratories (NASDAQ: IDXX) is 20.20%. Laboratories' PEG ratio is 2.59.

The trailing-twelve-month return on investment at SurModics (NASDAQ: SRDX) is 13.60%. SurModics' profit margin for the same period is 23.20%.